rs3747763
Variant names: 
Your query was ambiguous. Multiple possible variants found: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_003913.5(PRP4K):c.2312+224G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.654 in 151,920 control chromosomes in the GnomAD database, including 32,800 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.65   (  32800   hom.,  cov: 31) 
Consequence
 PRP4K
NM_003913.5 intron
NM_003913.5 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  0.972  
Publications
4 publications found 
Genes affected
 PRP4K  (HGNC:17346):  (pre-mRNA processing factor kinase PRP4K) Pre-mRNA splicing occurs in two sequential transesterification steps, and the protein encoded by this gene is thought to be involved in pre-mRNA splicing and in signal transduction. This protein belongs to a kinase family that includes serine/arginine-rich protein-specific kinases and cyclin-dependent kinases (CDKs). This protein is regarded as a CDK-like kinase (Clk) with homology to mitogen-activated protein kinases (MAPKs). [provided by RefSeq, Jul 2008] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89). 
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.755  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| PRP4K | NM_003913.5 | c.2312+224G>A | intron_variant | Intron 10 of 14 | ENST00000337659.11 | NP_003904.3 | 
Ensembl
Frequencies
GnomAD3 genomes  0.654  AC: 99320AN: 151802Hom.:  32776  Cov.: 31 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
99320
AN: 
151802
Hom.: 
Cov.: 
31
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.654  AC: 99392AN: 151920Hom.:  32800  Cov.: 31 AF XY:  0.655  AC XY: 48671AN XY: 74252 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
99392
AN: 
151920
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
48671
AN XY: 
74252
show subpopulations 
African (AFR) 
 AF: 
AC: 
23188
AN: 
41406
American (AMR) 
 AF: 
AC: 
10861
AN: 
15258
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
2322
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
3997
AN: 
5160
South Asian (SAS) 
 AF: 
AC: 
3232
AN: 
4818
European-Finnish (FIN) 
 AF: 
AC: 
7202
AN: 
10548
Middle Eastern (MID) 
 AF: 
AC: 
193
AN: 
292
European-Non Finnish (NFE) 
 AF: 
AC: 
46342
AN: 
67954
Other (OTH) 
 AF: 
AC: 
1393
AN: 
2100
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.502 
Heterozygous variant carriers
 0 
 1741 
 3482 
 5222 
 6963 
 8704 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 810 
 1620 
 2430 
 3240 
 4050 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
2572
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.